Analyzing actual risk in malaria-deferred donors through selective serologic testing

Transfusion

Volumn 53, Issue 8, 2013, Pages 1736-1743

  Nguyen, Megan L ^b   Goff, Tami ^a   Gibble, Joan ^a   Steele, Whitney R ^a   Leiby, David A ^a  

^a AMERICAN RED CROSS   (United States)

^b Transmissible Diseases Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DONOR SELECTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEXICO; PLASMODIUM MALARIAE INFECTION; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; TRAVEL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; BIOLOGICAL MARKERS; BLOOD DONORS; DNA, PROTOZOAN; DONOR SELECTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALARIA; MALE; MEXICO; MIDDLE AGED; PLASMODIUM; QUESTIONNAIRES; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84882372984     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12004     Document Type: Article

References (25)

1. Lee KS, Divis PC, Zakaria SK, Matusop A, Julin RA, Conway DJ, Cox-Singh J, Singh B,. Plasmodium knowlesi: reservoir hosts and tracking the emergence in humans and macaques. Plos Pathog 2011; 7: e1002015.
2. World Health Organization. World malaria report 2011. Geneva: World Health Organiztion; 2011. [cited 2012 Jul 1]. Available from: URL: http://www.who.int/malaria/world-malaria-report-2011/9789241564403-eng.pdf
3. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD,. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012; 379: 413-431.
4. Mali S, Kachur SP, Arguin PM,. Malaria surveillance-United States, 2010. MMWR Surveill Summ 2012; 61: 1-17.
5. Mungai M, Tegtmeier G, Chamberland M, Parise M,. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 1973-1978.
6. Gonzalez CL, Arguin P, Barnwell J, Wilkins P, Leiby DA, Nguyen M, Lendio P, Studemeister A, Galel SA,. Transfusion-transmitted falciparum malaria from an asymptomatic donor. Transfusion 2011; 51: 197A.
7. Leiby DA, Nguyen ML, Notari EP,. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008; 48: 2222-2228.
8. Custer B, Chinn A, Hirschler NV, Busch MP, Murphy EL,. The consequences of temporary deferral on future whole blood donation. Transfusion 2007; 47: 1514-1523.
9. Spencer B, Steele W, Custer B, Kleinman S, Cable R, Wilkinson S, Wright D,. Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion 2009; 49: 2335-2345.
10. Stramer SL,. Issues with malaria screening in the US. Rockville (MD): U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER); 2006. [cited 2012 Jul 1]. Available from: URL: http://www.fda.gov/ downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ ucm091928.pdf
11. Seed CR, Kee G, Wong T, Law M, Ismay S,. Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang 2010; 98: e182-192.
12. Garraud O, Assal A, Pelletier B, Danic B, Kerleguer A, David B, Joussemet M, de, Micco P,. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95: 226-231.
13. Kitchen AD, Barbara JA, Hewitt PE,. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005; 89: 77-80.
14. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K,. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 2004; 42: 5636-5643.
15. World Health Organization. International travel and health, country list, 2012. [cited 2012 Jul 1]. Available from: URL: http://www.who.int/ith/chapters/ ith2012en-countrylist.pdf
16. Seed CR, Cheng A, Davis TM, Bolton WV, Keller AJ, Kitchen A, Cobain TJ,. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang 2005; 88: 98-106.
17. Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland O, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S,. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010; 98: 468-478.
18. Centers for Disease Control and Prevention (CDC). Transfusion-transmitted malaria-Missouri and Pennsylvania, 1996-1998. MMWR Morb Mortal Wkly Rep 1999; 48: 253-256.
19. Weiss GE, Traore B, Kayentao K, Ongoiba A, Doumbo S, Doumtabe D, Kone Y, Dia S, Guindo A, Traore A, Huang CY, Miura K, Mircetic M, Li S, Baughman A, Narum DL, Miller LH, Doumbo OK, Pierce SK, Crompton PD,. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. Plos Pathog 2010; 6: e1000912.
20. Soe S, Khin Saw A, Htay A, Nay W, Tin A, Than S, Roussilhon C, Perignon JL, Druilhe P,. Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Trans R Soc Trop Med Hyg 2001; 95: 81-84.
21. Wilson M, Sulzer AJ, Runcik K,. Malaria-antibody patterns as determined by the IFA test in U.S. servicemen after chemotherapy. Am J Trop Med Hyg 1970; 19: 401-404.
22. Spencer B, Kleinman S, Custer B, Cable R, Wilkinson SL, Steele W, High PM, Wright D,. Deconstructing the risk for malaria in United States donors deferred for travel to Mexico. Transfusion 2011; 51: 2398-2410.
23. FDA Blood Products Advisory Committee. Transcript of 96th meeting of Blood Products Advisory Committee, U.S. Food and Drug Administration, Nov 16, 2009; Bethesda, MD. [cited 2012 Jul 1]. Available from: URL: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/ BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm121612.htm
24. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, John RS, Sher G, Goldman M, Ricketts M, Kain KC,. Transfusion-transmitted malaria in Canada. CMAJ 2001; 164: 377-379.
25. Food and Drug Administration. Guidance for industry: recommendations for donor questioning, deferral, reentry and product management to reduce the risk of transfusion-transmitted malaria. June 2012. [cited 2012 Jul 1]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm077061.htm